Intrinsic value of 4D Molecular Therapeutics, Inc. (FDMT)
Live fair value data for 4D Molecular Therapeutics, Inc. (FDMT) is currently unavailable. Please check again shortly.
Current Price: $309.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is 4D Molecular Therapeutics, Inc. (FDMT) undervalued or overvalued?
Based on the current model output, 4D Molecular Therapeutics, Inc. appears to be overvalued with a downside of 8.00%.
Fair value vs market price — 4D Molecular Therapeutics, Inc. (FDMT)
Unlock premium access to view the live fair value comparison against current market price for FDMT.
Frequently Asked Questions - FDMT
How is FDMT intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for FDMT.
Is FDMT undervalued or overvalued right now?
FDMT is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for FDMT: open their intrinsic value pages.